Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Gyre Therapeutics Inc (GYRE)

NASDAQ
Currency in USD
Disclaimer
17.1100
+0.7800(+4.78%)
Closed
After Hours
16.8600-0.2500(-1.4611%)

GYRE Technical Analysis

Summary

Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Buy

Summary:Strong Buy

Moving Averages:BuyBuy: (11)Sell: (1)
Technical Indicators:Strong BuyBuy: (8)Sell: (0)

Technical Indicators

Summary: Strong BuyBuy: 8Neutral: 0Sell: 0
Apr 26, 2024 23:48 GMT
Name
Value
Action
RSI(14)61.272Buy
STOCH(9,6)87.145Overbought
STOCHRSI(14)80.023Overbought
MACD(12,26)0.38Buy
ADX(14)28.266Buy
Williams %R-13.123Overbought
CCI(14)95.4067Buy
ATR(14)0.4439High Volatility
Highs/Lows(14)0.4439Buy
Ultimate Oscillator62.582Buy
ROC6.383Buy
Bull/Bear Power(13)0.992Buy

Moving Averages

Summary: BuyBuy: 11Sell: 1
Apr 26, 2024 23:48 GMT
Name
Simple
Exponential
MA5
17.0770
Sell
16.9883
Buy
MA10
16.7145
Buy
16.7458
Buy
MA20
16.2572
Buy
16.4154
Buy
MA50
15.8947
Buy
16.1386
Buy
MA100
16.0667
Buy
16.2067
Buy
MA200
16.6318
Buy
16.4210
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic16.716616.823317.036617.143317.356617.463317.6766
Fibonacci16.823316.945517.021117.143317.265517.341117.4633
Camarilla17.16217.191317.220717.143317.279317.308717.338
Woodie's16.7716.8517.0917.1717.4117.4917.73
DeMark's--17.0917.1717.41--
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.